|
||
By

From * Department of Human Immunology and In this study it is shown that both membrane-bound and soluble forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B
cells. Activated B cells express the membrane-bound form of SLAM (mSLAM), the soluble (s)
and the cytoplasmic (c) isoforms of SLAM, and the expression levels of mSLAM on B cells are
rapidly upregulated after activation in vitro. Importantly, recombinant sSLAM and L cells
transfected with mSLAM efficiently enhance B cell proliferation induced by anti-µ mAbs,
anti-CD40 mAbs or Staphylococcus aureus Cowan I (SAC) in the presence or absence of IL-2,
IL-4, IL-10, IL-12, or IL-15. sSLAM strongly enhances proliferation of both freshly isolated B
cells and B cells derived from long-term in vitro cultures, indicating that SLAM acts not only
during the initial phase of B cell activation but also during the expansion of preactivated B cells.
In addition, sSLAM enhances production of IgM, IgG, and IgA by B cells activated by antiCD40 mAbs. SLAM has recently been shown to be a high affinity self-ligand, and the present
data suggest that signaling through homophilic SLAM-SLAM binding during B-B and B-T
cell interactions enhances the expansion and differentiation of activated B cells.
Department of Molecular Biology, DNAX Research
Institute of Molecular and Cellular Biology, Palo Alto, California 94304
This article has been cited by other articles:
| TABLE OF CONTENTS |
|